LOGIN
Tetrahydrocannabinol 8mg does not demonstrate better efficacy vs diazepam for chronic pancreatitis
September 2018
Tetrahydrocannabinol 8mg does not demonstrate better efficacy vs diazepam for chronic pancreatitis
Study Type:Randomized Trial
OE Level Evidence:2
Journal Level of Evidence:N/A
Single dose delta-9-tetrahydrocannabinol in chronic pancreatitis patients: Analgesic efficacy, pharmacokinetics and tolerability
Br J Clin Pharmacol. 2016 Mar;81(3):525-37. doi: 10.1111/bcp.12811Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
22 patients with chronic pancreatitis took 8 mg of delta-9-tetrahydrocannbinol (Δ9-THC) with placebo diazepam or placebo Δ9-THC with diazepam at 2 sessions in a randomly allocated sequence for this crossover trial. Blood samples were examined for the pharmacokinetic and pharmacodynamic properties of Δ9-THC, and reduction in pain was measured by the VAS scale. Bond and Lader visual analogue scales ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.